跳至主要内容
临床试验/NCT01841294
NCT01841294Unknown4 期

NK Activity Modulation by Intravenous Lidocaine During Laparoscopic Colorectal Surgery

Maisonneuve-Rosemont Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2012年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
50
试验地点
1
主要终点
Dosage of NKs activity after surgery

研究概览

简要总结

Surgical resection is the best treatment option for colorectal cancer. Despite this radical approach, recurrences within five years are still common. Several authors have proposed that the immunosuppressive state surrounding the perioperative period was a key element of cancer cells spread.

A particular subtype of T lymphocytes, the Natural Killer cells (NKs), is the main actor of the innate immune system. Several factors of the perioperative period can reduce activity of NKs such as stress, pain, opioids and general anaesthetics.

Lidocaine is a local anaesthetic that has been widely used intravenously for abdominal surgeries. Intravenous lidocaine has been shown to reduce pain scores, morphine consumption, ileus time and length of stay in major colorectal surgeries. It reduced markers of systemic inflammation as well.

The authors hypothesize that the use of intravenous lidocaine during laparoscopic surgeries for colorectal cancer resection will preserve NKs activity.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients admitted for resection of colorectal cancer under laparoscopic surgery
  • American Society of Anesthesiologists class I-III.
  • The subject is able to understand the study objectives, the experimental protocol and procedures, and is capable of providing an informed consent.

排除标准

  • Subjects allergic to any of the study drugs.
  • BMI > 35 kg/m
  • Severe renal or hepatic failure.
  • Pregnancy.
  • Emergent procedure.
  • Heart failure NYHA > III.
  • Systolic blood pressure < 90 mmHg.
  • Advanced heart block (unless patient has a pacemaker).
  • Unstable angina and/or myocardial infarction within past 6 weeks.
  • FEV1 ≤ 0.8 L.
  • Oxygen-dependent patient.
  • Electrocardiographic abnormalities
  • Treatment with immunosupressive drugs, corticosteroids, NSAIDS, antiarythmic
  • Morphine intolerance or allergy

研究组 & 干预措施

Intravenous Lidocaine

Experimental

Patients undergoing laparoscopic surgery for resection of colorectal cancer will benefit of an infusion of intravenous lidocaine from the induction of anesthesia untill one hour after PACU admission

干预措施: Intravenous Lidocaine (Drug)

Placebo

Placebo Comparator

Infusion of normal saline form the induction of anaesthesia untill one hour after PACU admission

干预措施: Normal saline infusion (Drug)

结局指标

主要结局

Dosage of NKs activity after surgery

时间窗: compare the activity of NK cells on day 1 and day 3 after surgery

Dosage of NKs activity after surgery

次要结局

  • Pain scores(pain scores from the PACU to the 3rd day after surgery)
  • Morphine consumption(From the PACU to the 3rd day after surgery)
  • Ileus time(Day 1 and Day 3 after surgery)
  • Surgical complications(Within 3 days after surgery)
  • Fentanyl dose(Operative time)
  • Nausea and vomiting(From the PACU to the 3rd day after surgery)
  • Major adverses events(Start of the surgery untill one hour after PACU ad;ission)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Louis-Philippe Fortier

Principal investigator

Maisonneuve-Rosemont Hospital

研究点 (1)

Loading locations...

相似试验

尚未招募
不适用
atural Killer cel therapie tegen teruggekeerde eierstokkanker.Recurrent ovarian carcinoma, recidief ovarium carcinoom. immunotherapy, immuuntherapie.
NL-OMON20648Radboudumc12
Unknown
不适用
Influence of the Surgical Technique Used for Colectomies on the Concentration of Circulating Tumor DNA and the Presence of Circulating Tumor Cells: Comparison of the "no Touch" Technic With Either First Clamping of the Mesenteric Vessels or First Mobilization of the Tumor Followed by Clamping.Colorectal Cancer
NCT03809403Assistance Publique - Hôpitaux de Paris40
进行中(未招募)
1 期
Treatment of bowel cancer using a different approach than surgery using a new device that makes the tumor absorb more drug while leaving the healthy tissue alone.MedDRA version: 17.0Level: PTClassification code 10052358Term: Colorectal cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 17.0Level: HLTClassification code 10010039Term: Colorectal and anal neoplasms malignancy unspecifiedSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 17.0Level: HLTClassification code 10010023Term: Colorectal neoplasms malignantSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 17.0Level: HLTClassification code 10010040Term: Anal and colorectal neoplasms NECSystem Organ Class: 100000004856Colorectal cancer
EUCTR2012-001248-23-DKAll Ireland Cooperative Oncology Research Group30
进行中(未招募)
1 期
A randomized phase 3 study of treatment strategies for patients with colon cancer with metastases only in the liver, which is (at this moment) not eligible for surgical treatment. A study of the Dutch Colorectal Cancer Group (DCCG).
EUCTR2013-005435-24-NLDutch Colorectal Cancer Group584
招募中
3 期
Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases. CAIRO5 a randomized phase 3 study of the Dutch Colorectal Cancer Group (DCCG)Bowel Cancer10017991Colorectal cancer
NL-OMON54605Dutch Colorectal Cancer Group584